Molecular Forecaster Continues Quest to Fast Track Drug Discovery with Two New Public-Private Partnerships
- Written by Newsfile
The company and its partners have secured CAD$1 million to apply and improve MFI's virtual drug-design software in support of preclinical research targeting antibiotic-resistant bacteria and non-alcoholic fatty liver disease
Montreal, Quebec--(Newsfile Corp. - September 28, 2021) - Molecular Forecaster Inc. (MFI) is excited to announce it has...